baber/WOPTO huggingface dataset:
Patent NZ-569462-A (NZ)
Title: An edge protector is formed and adhesive used to secure the two sidesof a groove which are held in shape while curing
Inventor: BERLO PATRICK PETRUS ANTONIUS MARIA VAN
IPC: B31B50/46
Filed: 2008-06-26
Abstract: A method and machine for forming an edge protector (1) from a panel is disclosed. The method includes the steps of a) forming a channel in the panel; b) applying adhesive into the channel; c) folding the panel to close the channel; and d) holding the panel within a receptacle (16) until the adhesive has formed a bond within the channel. The channel may be cut with a disc cutter or by slitting the panel partly through, then deforming the panel about the slit. The protector (1) is pushed into the receptacle (16) by a ram (18), with each successive protector (1) pushing the previously formed protectors (1) further through the receptacle (16). When a protector (1) is finally pushed out of the receptacle (16), the adhesive will have cured and the shape of the protector (1) is maintained by the bond in the channel. A step for cutting the protector to length may also be included before the holding stage.
Patent NZ-574150-A (NZ)
Title: Beverage machine and piercing member for introducing hot water downward into a container for infusing the tea within
Inventor: OZANNE MATTHIEU
IPC: A47J31/36
Filed: 2009-01-13
Abstract: A beverage machine with an injecting means (100) for piercing a capsule is disclosed. The brewing device comprises a means for retaining the capsule in a defined position and an injecting means (100) for injecting hot water into the capsule while the capsule is retained in the defined position. The injecting means (100) has a piercing member (102) with an internal axial channel (110) for guiding the hot water. The internal axial channel is essentially horizontally oriented when the piercing member (102) has penetrated the capsule's shell. The injecting means (110) also has at least one outlet opening (114) for directing hot water downwards to the lowermost part of the capsule while the capsule is retained in the defined position.
Patent NZ-575475-A (NZ)
Title: A combined wind and gas engine where the wind engine includes an impeller and an impeller chamber
Inventor: CONG YANG
IPC: F03D9/00
Filed: 2007-08-16
Abstract: A combined wind and gas engine includes an independent high-pressure gas engine 20 and a wind resistance engine 22. The first high pressure gas engine comprises at least one first impeller chamber, at least one first impeller and at least one first air-jet nozzle. The impeller chamber is provided with a gas inlet and an exhaust vent. The first impeller is installed inside the first impeller chamber and coupled to a first shaft. The first air-jet nozzle is for jetting a high pressure gas through the gas inlet into the first impeller chamber and is installed at a casing of the first impeller chamber. The first impeller outputs primary power through the first shaft. The wind resistance engine comprises at least one second impeller chamber 221 and at least one second impeller 222 installed inside the second impeller chamber 221 where the second impeller 222 is coupled to a second shaft. An air inlet 51 for receiving external wind resistance airflow and an air outlet for exhausting gas are provided at a casing of the second impeller chamber. A wind resistance airflow entering the second impeller chamber drives the second impeller to rotate to generate auxiliary power which is outputted through the second shaft.
Patent NZ-582997-A (NZ)
Title: Medical triage system
Inventor: HUFFINE THOMAS S
IPC: G05B19/418
Filed: 2005-11-08
Abstract: A computer system and a method for enabling a triage operator to determine medical triage disposition for a person are disclosed. The system includes a processor, a display and a database having stored therein at least a plurality of triage categories. Each of the plurality of triage categories comprises questions grouped into a plurality of tiers ranked according to urgency, and each of the plurality of tiers corresponds to one of a set of triage dispositions. The triage categories comprise body parts, injury types, symptoms, or a combination thereof. The processor is configured with programming code to provide selection by a triage operator of at least a first relevant triage category and a second relevant triage category from the plurality of triage categories based on answers received from the person in response to an initial inquiry into a medical condition of the person and to provide simultaneous access to the triage operator in a computer screen layout in the display to the questions related to the selected relevant triage categories. The processor is further configured with programming code to provide triage by the triage operator with access to the computer system with the triage being provided to the person remotely through a form of remote communication, without access to trained medical personnel. The providing triage comprises (a) identifying from all of the selected relevant triage categories a highest urgency tier that has at least one unasked question; (b) presenting one of the at least one unasked question of the highest urgency tier to the person; (c) receiving a response from the person to the at least one unasked question; and (d) repeating (a) through (c) for all of the selected triage categories until the triage disposition is determined.
Patent NZ-584314-A (NZ)
Title: A red and green dry adhesive, a method producing the same
Inventor: SUN DANJIU
IPC: C09J179/00
Filed: 2008-09-01
Abstract: Disclosed is a red and green dry adhesive, which contains component A and component B, the two components become white after mixing; wherein the component A which is red comprises 20-30 parts by weight epoxy resin, 0-3 parts by weight coupling agent (such as vinyl silane, g-propyltrimethoxysilane, aminopropyltriethoxysilane or anilinomethyltriethoxysilane), 1-5 parts by weight reactive diluents, 20-60 parts by weight inorganic filler (such as calcium carbonate, fine silicon powder, barium sulfate, alumina, magnesia, talcum powder, white carbon black, bentonite or titanium pigment), 0.1-1 parts by weight red organic color paste (which comprises a pigment such as lithol scarlet, pigment scarlet powder, toluidine red, or lightfast red), while component B which is green comprises 5-15 parts by weight organic modified amine hardener (such as a low molecular polyamide, phenalkamines, aliphatic amines, aliphatic cyclic amines, or aromatic amines), 3-5 parts by weight coupling agent, 15-50 parts by weight inorganic filler, 3-10 parts by weight promoter (such as 2,4,6-tri(dimethylamino)phenol, N,N-dimethylbenzylamine, N,N-dimethylaniline or b-hydroxyethyl diamine), 0-5 parts by weight thickener (such as hydroxyethyl cellulose), 0-5 parts by weight reactive diluents, and 0.1-2 parts by weight green organic color paste (which comprises a pigment such as benzimidazolone azo yellow, isoindolinone yellow, medium chrome yellow or aniline yellow with one or more of pigments selected form fluorescence blue and/or phthalocyanine blue).
Patent NZ-584797-A (NZ)
Title: Mask cushioning structure having first and second gel filling materials
Inventor: SKIPPER CHRISTOPHER SCOTT
IPC: B29C65/56
Filed: 2008-11-17
Abstract: A cushion assembly for use with a respiratory mask includes a bladder filled with the combination of a gel (740) having a first indentation hardness and a gel (750) having a second indentation hardness. A seal forming structure is formed in one piece with the cushioning structure. The seal forming structure includes a thin membrane flap that is structured to provide a seal to the patient's face. The thin membrane flap includes a free end that is spaced from the cushioning structure in its substantially relaxed, unstressed state and is adapted to be responsive to a difference between mask pressure and ambient pressure to effect a seal with a face region of a patient.
Patent NZ-585516-A (NZ)
Title: Anti-cd20 antibody formulation
Inventor: ADLER MICHAEL
IPC: A61K47/18
Filed: 2008-12-11
Abstract: Provided is a formulation comprising: - about 10 to about 30 mg/mL of a type II anti-CD20 antibody, wherein said antibody is a humanized B-Lyl antibody, - optionally about 0.001 to about 1 % w/v of at least one pharmaceutically acceptable surfactant, and - about 1 to about 100 mM of a buffer selected from histidine-buffers, citrate-buffers, succinate-buffers, acetate-buffers and phosphate buffers, - at apH of about 4.5 to about 7.0. Further provided are variants for the formulation.
Patent NZ-587067-A (NZ)
Title: Substituted arylamide oxazepinopyrimidone derivatives
Inventor: FAYOL AUDE
IPC: A61K31/33
Filed: 2009-01-27
Abstract: Disclosed are pyrimidine derivatives, represented by general formula (I), which comprises a cycloheptane ring where a carbon atom in the ring has been replaced by an oxygen atom. An example of such a compound falling within the scope of formula (I) is (+/-)-4-Chloro-2-methoxy-N-(4-oxo-2-pyrimidin-4-yl-5,6,8,9-tetrahydro-4H- 7-oxa-1,4a-diaza-benzocyclohepten-9-y1)-benzamide. Also disclosed is the use of the compounds of formula (I) for treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease, bone diseases and cancer.
Patent NZ-588011-A (NZ)
Title: Heterocyclic compounds having glucagon antagonistic action useful for treating diabetes
Inventor: BANNO YOSHIHIRO
IPC: A61K31/343
Filed: 2009-03-04
Abstract: Disclosed are compounds of Formula (IA), salts thereof, and methods for their preparation. Also disclosed are compounds of Formula (I), which differ from Formula (IA) in that the bicyclic moiety AC-AB of (IA) is instead a pyrazole ring. Specific examples of compounds of Formula (IA) and Formula (I) include: 3-[({ 4-[(Cyclohexyl{ 3-methyl-1-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl} methyl)amino]phenyl} carbonyl)amino]propanoic acid, 3-[{ [4-({ Cyclohexyl[1-(3-methoxyphenyl)-3-methyl-1H-pyrazol-4-yl]methyl} amino)phenyl]carbonyl} (methyl)amino]propanoic acid, and 3-{ [(5-{ [Cyclohexyl(5-fluoro-3-methyl-1-benzofuran-2-yl)methyl]amino} pyridin-2-yl)carbonyl](methyl)amino} propanoic acid. The compounds are useful as glucagon antagonists and can operate as sugar production-suppressive agents for treating diabetes.
Patent NZ-590440-A (NZ)
Title: Improvements in and relating to grease conversion and apparatus therefor
Inventor: TUNLEY ANDREW
IPC: B01D21/02
Filed: 2011-01-12
Abstract: 590440 Disclosed is a fluid treatment device (1) adapted to be connected inline in a wastewater system. The device has an enclosure (12) substantially separated into at least a first treatment area (13) adjacent to an inlet (4) to the enclosure (12) and a second treatment area (14) adjacent to an outlet (5) of the enclosure (12) by baffle means which may include a primary baffle (16). The baffle means extends from below a normal wastewater level in the enclosure, to above the normal wastewater level. An opening (15) between the first (13) and second (14) treatment area a predetermined distance below the normal wastewater level allows passage of wastewater from the inlet (4) into the first treatment area (13), through the opening (15) into the second treatment area (14) and to the outlet (5). A bio-augmentation feed including a discharge outlet is positioned in the first treatment area (13), the bio-augmentation feed being in controllable communication with a bio-augmentation reservoir and controllable supply means.
Patent NZ-591166-A (NZ)
Title: Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
Inventor: WANG BING
IPC: A61K33/243
Filed: 2009-07-27
Abstract: Substituted pyrido-phthalazin-one derivatives having the structure set forth in Formula (I) and Formula (II) are disclosed, wherein the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined in the specification. These compounds are inhibitors of poly(ADP-ribose)polymerase activity. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat diseases, disorders and conditions that are ameliorated by the inhibition of PARP activity.
Patent NZ-596729-A (NZ)
Title: Methods for identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator
Inventor: KIRCHHOFER DANIEL K
IPC: A61K31/00
Filed: 2007-06-20
Abstract: Disclosed is a method of identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator (pro-uPA), said method comprising: (a) Contacting a candidate substance with a first sample comprising hepsin and a pro-uPA substrate, and (b) Comparing amount of pro-uPA substrate activation in the sample with amount of pro-uPA substrate activation in a reference sample comprising similar amounts of hepsin and pro-uPA substrate as the first sample but that has not been contacted with said candidate substance, whereby a decrease in amount of pro-uPA substrate activation in the first sample compared to the reference sample indicates that the candidate substance is capable of inhibiting hepsin activation of single chain uPA (pro-uPA).
Patent NZ-597833-A (NZ)
Title: Benzoxazepin pi3k inhibitor compounds and methods of use
Inventor: DO STEVEN
IPC: C07D498/14
Filed: 2010-09-27
Abstract: 597833 The disclosure relates to benzoxazepin compounds of formula (I) including stereoisomers, geometric isomers, tautomers, or pharmaceutically acceptable salts thereof, wherein: Z1 is CR1 or N; Z2 is CR2 or N; Z3 is CR3 or N; Z4 is CR4 or N; and B is a pyrazolyl, imidazolyl, or triazolyl ring, R1, R2, R3 & R4 are as defined in the specification. Examples of such compounds are 1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol and 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol. These compounds have PI3 kinase inhibiting activity and are suitable for treating cancer.
Patent NZ-602072-A (NZ)
Title: Methods for inhibiting angiogenesis using egfl8 antagonists
Inventor: YE WEILAN
IPC: A61K38/18
Filed: 2009-01-14
Abstract: Disclosed is the use of an EGFL8 antagonist in the manufacture of a medicament for reducing or inhibiting angiogenesis in a subject having a pathological condition associated with angiogenesis, wherein the EGFL8 antagonist is an antagonist antibody or antibody fragment, a fragment or amino acid sequence variant of a native EGLF8 polypeptide, an antisense RNA or DNA construct, an inhibitory duplex RNA, a ribozyme, a nucleic acid in triple-helix formation, or an RNAi.
Patent NZ-607809-A (NZ)
Title: Improvements in and rrelating to paperboard manufacture
Inventor: VAN BERLO PATRICK PETRUS ANTONIUS MARIA
IPC: B31F1/28
Filed: 2012-06-15
Abstract: 607809 A machine for producing corrugated paperboard which includes: an endless fluted conveyor belt assembly having an endless fluted conveyor belt including a plurality of adjacent flutes thereon wherein the flutes are configured to correspond to the teeth on a corrugating roller which is located at the upstream end of the endless fluted conveyor assembly; at least one source of electromagnetic radiation and associated support surface located downstream of a glue applicator, the associated support surface also positioned substantially parallel to, the plane of the endless fluted conveyor belt said associated support surface also being sufficiently proximate to the flutes on the endless fluted conveyor belt, so as in use，to be capable of at least partially holding newly glued planar sheet and corrugated sheet material together.
Patent NZ-609017-A (NZ)
Title: Method and apparatus for distributing articles in a storage compartment
Inventor: PAPE HENRIK
IPC: F25C5/00
Filed: 2011-08-30
Abstract: A method of distributing articles (16) made by serial production into a storage unit (15), comprising distributing an article (16) onto an article conveyor on a transport platform (25) of an article distributing apparatus positioned in a start position above a storage area within a storage unit (15), selecting a storage position in the storage area from a plurality of adjacent article storage positions in at least one row extending along the storage area beneath the article conveyor, driving the transport platform (25) in a horizontal transport direction to a location above the selected storage position, actuating the article conveyor to transport the article off the platform (25), whereby the article (16) falls onto a floor of the storage area at the selected storage position or onto a stack of previously stacked articles (16) at the selected storage position, driving the transport platform (25) back to the start position to receive a subsequent article (16) to be distributed into the storage area, and repeating the foregoing steps to distribute a plurality of articles (16) one by one to selected storage positions in the storage area.
Patent NZ-609219-A (NZ)
Title: Anticancer fusion protein
Inventor: PIECZYKOLAN JERZY SZCZEPAN
IPC: C12N15/62
Filed: 2012-01-05
Abstract: Disclosed is a fusion protein comprising: domain (a) comprising a functional fragment of soluble hTRAIL protein sequence starting with amino acid in a position not lower than hTRAIL95 or a sequence having at least 70% sequence identity with said functional fragment; and domain (b) constituting a sequence of anti-angiogenic effector peptide which is the inhibitor of growth factor receptor and is selected from the group of growth factor fragments consisting of VEGF fragment of SEQ. No. 17, PDGF fragment of SEQ. No. 22 and EGF fragment of SEQ. No. 23; the sequences as disclosed in the specification; wherein the sequence of domain (b) is attached at C - terminus or N - terminus of domain (a).
Patent NZ-615308-A (NZ)
Title: Antibody-drug conjugates
Inventor: GERBER HANS-PETER
IPC: A61P35/00
Filed: 2012-03-19
Abstract: Discloses an antibody-drug conjugate of the formula: Ab-(LU-D)p or a pharmaceutically acceptable salt thereof wherein; (a) Ab is an anti-5T4 antibody or antigen binding portion thereof, comprising: (i) a VH CDR1 region as shown in SEQ ID NO: 5, (ii) a VH CDR2 region as shown in SEQ ID NO: 6, (iii) a VH CDR3 region as shown in SEQ ID NO: 7, (iv) a VL CDR1 region as shown in SEQ ID NO: 8, (v) a VL CDR2 region as shown in SEQ ID NO: 9, and (vi) a VL CDR3 region as shown in SEQ ID NO: 10, (b) LU is a maleimidocaproyl linker unit, (c) p is an integer from 1 to 8, and (d) D is a Drug unit selected from the group consisting of monomethylauristatin E (MMAE) and monomethylauristatin F (MMAF); wherein the sequences are as defined in the complete specification.
Patent NZ-617752-A (NZ)
Title: Container and lifting means for an article
Inventor: NADEAU SANDRINE
IPC: B65D85/10
Filed: 2012-06-13
Abstract: A container (1) comprising a box (2), and a lid (3), wherein a lifting means (41) for articles (42), in particular smoking articles, is provided in the container. The lifting means comprises a lifting panel (45) which is hingedly connected via a first hinge line (44) to the inside of a bottom wall (4) of the box, and a back-folding panel (47) disposed between the lifting panel and the lid, and depending from the lifting panel via a second hinge line. The back-folding panel is adapted to transfer a movement of the lid to the lifting panel, such that the lifting panel is lifted when the lid is moved in the open position. The lifting panel further comprises a holding means with a cut-out (48) provided in the lifting panel, the cut-out extending from the lifting panel over the second hinge line and into the back-folding panel, the cut-out being adapted to at least partially receive the article. The lifting means is configured such that the back-folding panel extends towards the bottom wall of the box, at least when the lifting means is arranged in the container with the lid in the open position. Also disclosed is a lifting means and the use of a lifting means.
Patent NZ-626503-A (NZ)
Title: Tannery process with effluent recycling
Inventor: ZHANG ZHUANGDOU
IPC: C02F103/24
Filed: 2014-06-20
Abstract: Industrial tanning process recycles tanning wastewater. Recyclying includes collecting, filtering and seperating of effluent material. Recycling is carried out after each step. Steps may include soaking, liming, re-liming, de-liming bating, pickling chrome tanning, re-tanning, neutralizing, and dyeing. The wastewater from each step is processed separately from the other steps and the recycled wastewater is reused for the same tanning step it was effluent of, after adding additional chemicals as required.
Patent NZ-704057-A (NZ)
Title: System for the preparation of beverages
Inventor: FOSTER JODY JAMES
IPC: B65D85/816
Filed: 2013-07-09
Abstract: A system (1) for the preparation of beverages includes a beverage supply device (10) for delivering a dose of liquid through a liquid outlet (58) and a beverage receptacle (20) having a base having a liquid inlet (72). The supply device and beverage receptacle may be joined together using a coupling interface (44,46) for connecting the beverage supply device to the base of the beverage receptacle. This allows the liquid to flow into the bottle via the liquid inlet in the base of the beverage receptacle. The system may operate with capsule containing concentrated beverage and may include further accessories.
Patent NZ-708662-A (NZ)
Title: Policy implementation over lmr and ip networks
Inventor: CLIVE DOUGLAS HORN
IPC: H04W36/00
Filed: 2014-05-29
Abstract: A communication system is made up of a number of LMR and IP bearers including LTE and P25. The information flowing over the integrated system is managed according to the situational context of the user. A policy driven approach is described that uses user context as its inputs and converts this into actions that preferentially improves the communication for the user particularly as they move between the available networks.
Patent NZ-708669-A (NZ)
Title: Vaccine for intrauterine disease
Inventor: BICALHO RODRIGO
IPC: C12N1/20
Filed: 2013-10-08
Abstract: Provided are compositions and methods for use in prophylaxis of puerperal metritis and improving reproductive function of ruminants. The methods and compositions are for subcutaneous administration and are provided as veterinary compositions and as articles of manufacture. The veterinary composition comprises three proteins of F. necrophorum leukotoxin (LKT), E. coli type 1 fimbrial adhesin (FimH), and T. pyogenes pyolysin (PLO), and can further comprise inactivated whole cells of Escherichia coli (E. coli), Trueperella pyogenes (T. pyogenes) and Fusobacterium necrophorum (F. necrophorum).
Patent NZ-726909-A (NZ)
Title: Process for separating and recovering ethane and heavier hydrocarbons from lng
Inventor: PATEL KIRTIKUMAR NATUBHAI
IPC: F25J3/02
Filed: 2011-10-20
Abstract: A process for extracting heavier components from liquid/fluid streams such as Rich LNG (RLNG) stream(s) with the streamlined economy is disclosed. The process involves heating the RLNG stream in heat exchanger(s) (LNGX) against column overhead vapour stream; not requiring separation of Feed streams into feed and reflux by splitting either pre- or post- of heat LNGX. The source liquid RLNG is processed producing liquid NGL and at same time returning purified Lean LNG (LLNG) product in its Liquid LNG form. The process operates essentially without the need for compression equipment. The process further provides without compressors vaporized natural gas at pipeline pressure and specifications. This is a system that can flexibly change product compositions and specifications of product NGL/Lean LNG/Pipeline Gas and operate in both Pipeline Specification deep 99% Ethane (C2) Extraction and Ethane (C2) Rejection NGL recovery modes with economy of equipment and energy requirements.